Desktop Site
|
28 Mar 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Watch List
Get Quote
Notices
|
S&P
BSE SENSEX
73,651.35
+655.04
+0.90 %
Corporate Announcement
Security Code
524804
Company
AUROBINDO PHARMA LTD.
Exchange Received Time
17/05/2019 09:09:40
Exchange Disseminated Time
17/05/2019 09:09:50
Time Taken
00:00:10
USFDA Classifies The Inspection Of Aurobindo'S API/ Intermediates Facilities Of Unit I, IX And XI As OAI |
5/17/2019 9:09:41 AM
This is to inform that the Company has received letters from the USFDA classifying the inspections concluded at our API facilities of Unit I and XI and intermediates facility of unit IX in February 2019 as Official Action Indicated (OAI).
The Company has already submitted its initial response to USFDA. The Company is sending further updates on the committed corrective actions.
The Company is confident that these OAI classifications will not have an impact on disruption of supplies or the revenue from operations of these facilities.
Please take the information on record.
Attachment
<< Back
Recently Viewed